2019
DOI: 10.1186/s13000-019-0900-7
|View full text |Cite
|
Sign up to set email alerts
|

Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil

Abstract: BackgroundPrimary cutaneous CD30+ lymphoproliferative disorders (pc-CD30-LPD) are a group of clonal T cell lymphoproliferative disorders that despite very similar tumor histology follow different and characteristic clinical courses, suggesting a homeostatic role of the tumor microenvironment. Little is known about tumor microenvironment and there is almost no literature about PD-L1 expression in pc-CD30-LPD.MethodsThis retrospective study presents a fully clinicopathologically characterized series of pc-CD30-L… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Many subtypes of cutaneous T-cell lymphomas were described, and the most common ones are mycosis fungoides and Sézary syndrome. Primary cutaneous peripheral T-cell lymphoma-NOS (PTCL-NOS) is the rarest form of cutaneous T-cell lymphomas, accounting for approximately 2% of all cutaneous lymphomas [ 12 , 13 , 14 ]. PTCL-NOS is a diagnosis of exclusion, based on the presence of typical histopathological features of lymphoma, an aberrant T-cell immunophenotype, often with a loss of CD5 and CD7, and a clonal T-cell receptor (TCR) gene rearrangement, in the appropriate clinical context [ 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Many subtypes of cutaneous T-cell lymphomas were described, and the most common ones are mycosis fungoides and Sézary syndrome. Primary cutaneous peripheral T-cell lymphoma-NOS (PTCL-NOS) is the rarest form of cutaneous T-cell lymphomas, accounting for approximately 2% of all cutaneous lymphomas [ 12 , 13 , 14 ]. PTCL-NOS is a diagnosis of exclusion, based on the presence of typical histopathological features of lymphoma, an aberrant T-cell immunophenotype, often with a loss of CD5 and CD7, and a clonal T-cell receptor (TCR) gene rearrangement, in the appropriate clinical context [ 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%